Posted on Aug 04, 2004, 6 a.m.
By Bill Freeman
The business world and private research community is forging ahead in the broad field of regenerative medicine, based both on stem cell research and other technologies. This press release and others like it show that at least some venture capital is flowing - the potential revenue that will result form from cures for diabetes, Parkinson's, Alzheimer's and other age-related conditions are too large to pass up, even in this currently hostile legislative environment.
View the Article Under Discussion: http://biz.yahoo.com/prnews/040802/clm035_1.html
Read More Longevity Meme Commentary: http://www.longevitymeme.org/news/